ecog-acrin
No description yet: the sentence for this tag has not been written. 3 records carry it: 3 people.
3 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Barbara Burtness Professor of Medicine and Co-Leader, Developmental Therapeutics, Yale Cancer Center · Yale Cancer Center / Smilow Cancer Hospital Led KEYNOTE-048, which made pembrolizumab first-line therapy for recurrent or metastatic head and neck cancer. | Head and neck squamous cell carcinoma | none | head-and-neck, immunotherapy | ||
Christopher J. Sweeney Director, South Australian Immunogenomics Cancer Institute; Professor, University of Adelaide · South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide Led CHAARTED, which showed adding docetaxel to hormone therapy extends survival in newly metastatic prostate cancer. | Prostate cancer | none | prostate, trialist | ||
Joseph A. Sparano Chief, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai · The Mount Sinai Hospital / Tisch Cancer Institute Led TAILORx, which showed most women with intermediate Oncotype scores can safely skip chemotherapy. | HR-positive / HER2-negative breast cancer | none | breast, de-escalation |